Faze Medicines, Inc. — Form D
Faze Medicines, Inc. of Cambridge, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-12-22. The offering totals $81.0M, of which $30.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-12-22
- Form: D
- Accession: 0001837265-20-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $81.0M
- Amount sold: $30.4M
- Remaining: $50.6M
- Investors: 9
- Date of first sale: 2020-12-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-384105
Issuer
- Name: Faze Medicines, Inc.
- CIK: 0001837265
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 215 First Street, Suite 440, Cambridge, MA, 02142
- Phone: 617-460-6634
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Ed Freedman | Director | Cambridge, MA |
| Charles Homcy | Director | San Francisco, CA |
| Cary Pfeffer | Director | Boston, MA |
| Robert Tepper | Director | Cambridge, MA |
| Ed Freedman | Executive Officer | Cambridge, MA |
| Cary Pfeffer | Executive Officer | Boston, MA |
More